TUESDAY, SEPTEMBER 23, 2008
|
| 6:00 PM |
Chairman’s reception (by invitation only)
|
WEDNESDAY, SEPTEMBER 24, 2008
|
7:00 AM |
Badge Pickup
Georgia World Congress Center
Building B
|
8:00 AM |
Opening Remarks
Thomas H. Callaway, MD; President, Life Science Partner and Managing Director, Georgia Venture Partners
|
8:10 AM |
Introduction of James C. Greenwood
Phillip Street; Kilpatrick Stockton LLP
Biotech Innovation: Healing, Fueling & Feeding the World
James C. Greenwood; President and Chief Executive Officer, Biotechnology Industry Organization
|
8:30 AM |
Introduction of Tanja Popovic
Alexis V. Pezzullo; KPMG LLP
The Making of a Healthiest Nation: Not If. Not When. Now!
Tanja Popovic, MD, PhD; Chief Science Officer, U.S. Centers for Disease Control and Prevention
|
9:00 AM |
Introduction of Stephen A. Hill
Walt Linscott; Thompson Hine LLP
Biopharmaceuticals: Back to the Future
Stephen A. Hill, BM, BCh, MA, FRCS; President and Chief Executive Officer,
Solvay Pharmaceuticals
|
9:30 AM |
Introduction of The Honorable Louis W. Sullivan
Tina McKeon; Fish and Richardson P.C.
National Health Museum: The Global Center for Health and Wellness
The Honorable Louis W. Sullivan, MD; President Emeritus, Morehouse School of Medicine
|
9:50 AM |
|
|
|
DiagNano: A Nanotechnology Opportunity in the Diagnostic Marketplace
|
| |
|
Kristina Crockett, MBA; Project Manager, McKesson – RelayHealth |
| |
|
Laura Huffman, JD; IP Associate, King & Spalding |
| |
|
Brad Kairdolf; PhD candidate in Biomedical Engineering, Georgia Tech and Emory
|
10:00 AM |
Introduction the Exhibition, Poster Viewing and Morning Concurrent Focus Sessions
William Kitchens; Arnall Golden Gregory LLP
|
10:30 AM |
MORNING CONCURRENT FOCUS SESSIONS
(Click on the title of each session for its description)
|
|
Ia. Forces Shaping the Emerging Bioeconomy in Agriculture |
|
|
Clifton A. Baile, PhD; Moderator, Georgia Research Alliance Eminent Scholar in Agricultural Biotechnology and Distinguished Professor of Animal Science and Foods and Nutrition,
The University of Georgia |
|
|
Gregg W. BeVier, DVM, MBA; Moderator, Chief Executive officer, AgGlobalVision |
|
|
Dennis T. Avery; Senior Fellow of the Hudson Institute and Director of its Center for Global Food Issues |
| |
|
Don W. Mabe Jr.; Senior Vice President Regional Operations, Case Ready Division, Pilgrim’s Pride Corporation |
|
|
William H. Sperber, PhD; Global Ambassador for Food Protection, Cargill, Inc.
|
|
Ib. |
Traversing the Regulatory and Clinical Compliance Maze: From Preclinical to Market Approval |
|
|
David W. Mullis, Jr., PhD, RAC; Moderator, President, Mullis and Associates |
|
|
Stephanie E. Hubbard; Bioresearch Monitoring Specialist, Food and Drug Administration |
|
|
Alan G. Minsk; Partner and Chair of the Food and Drug Practice Team,
Arnall Golden Gregory LLP |
|
|
Mamta Trivedi; Global Senior Director, QLAB, Global Quality Assurance, Central Labs, Quintiles Transnational Corp.
|
|
Ic. The Next Generation of Georgia’s Life Science Companies |
|
|
H. Lee Herron, DVM; Moderator, Vice President of Commercialization,
Georgia Research Alliance |
Kurt Jacobus, PhD; Chief Executive Officer and President, MedShape Solutions, Inc.
|
| David Johnston, PhD; Chief Executive Officer, AerovectRx Corporation |
Jack Merritt; President and Chief Executive Officer, ICON Interventional Systems, Inc.
|
|
Id. Cardiovascular Innovation in Public-Private Partnerships |
|
|
Jay S. Yadav, MD; Moderator, Chairman and Chief Executive Officer, CardioMEMS |
|
|
Todd T. Sherer, PhD; Moderator, Associate Vice President for Research and Director,
Office of Technology Transfer, Emory University |
|
|
Nic Chronos, MD; President, St. Joseph’s Translational Research Institute |
|
|
Omar M. Lattouf, MD, PhD, FACS,FACC; Associate Professor of Surgery / Cardiothoracic, Emory University, Inventor, Founder and Principal of TransCardiac Therapeutics, Inc. |
|
|
Michele M. Molden, FACHE; President and Chief Executive Officer, Piedmont Heart Institute |
|
|
David L. West, PhD, MPH; Vice President, Medical Device Development, Quintiles Consulting
|
11:45 AM |
Lunch
|
12:45 PM |
Introduction of Research Advances in Georgia
Jack Capers; King and Spalding
|
| |
Research Advances in Georgia: Neuroscience - Sponsored by Solvay Pharmaceuticals, Inc. |
Georgia Life Sciences Summit 2008
Research Advances in Georgia: Neuroscience
|
| Neuroscience is one of the strongest areas of interdisiciplinary and inter-institutional research in Georgia. This research is pushing the envelope on one of science's last and most daunting frontiers — the brain. This work holds great promise for understanding basic brain function and treating illnesses such as Alzheimer's disease and post traumatic stress disorder. The Center for Behavioral Neuroscience will host this plenary session where speakers will discuss recent advances in neuroscience research from the laboratories of scientists at Georgia’s research universities. |
| |
Close |
|
|
|
H. Elliott Albers, PhD; Moderator, Regents Professor, Georgia State University, Director,
Center for Behavioral Neuroscience |
|
|
Dennis W. Choi, MD, PhD; Executive Director, Comprehensive Neurosciences Initiative, Professor of Neurology, Biology, and Pharmacology, Emory University |
|
|
Stephen P. DeWeerth, PhD;
Professor and Associate Chair for Graduate Studies, Wallace H. Coulter Department of Biomedical Engineering, Georgia Tech / Emory University |
|
|
Gaylen L. Edwards, DVM, PhD; Professor and Department Head, Department of Physiology and Pharmacology, College of Veterinary Medicine, The University of Georgia |
|
|
Peter R. MacLeish, PhD; Director, Neuroscience Institute, Morehouse School of Medicine |
|
|
Walt Wilczynski, PhD; Professor of Psychology, Director, Neuroscience Institute, Center for
Behavioral Neuroscience, Georgia State University |
|
|
Robert K. Yu, PhD, MedScD; Professor and Director, Institute of Molecular Medicine and Genetics,
Medical College of Georgia
|
2:10 PM |
Introduction of CartiMesh
Robert T. McNally, PhD; President and Chief Executive Officer, GeoVax
|
|
|
CartiMesh: A living implant for Healing Knee Cartilage |
|
|
Yash Kolambkar; Georgia Institute of Technology |
|
|
Ivan Mihailov; Emory University |
|
|
Anil Patel; Emory University |
|
|
Jordan Scott; Georgia Institute of Technology |
|
|
2:20 PM |
Exhibition and Scientific Poster Viewing
|
2:50 PM |
AFTERNOON CONCURRENT FOCUS SESSIONS
(Click on the title of each session for its description) |
|
IIa. |
Medical Devices in Georgia
presented in partnership with the Southeast
Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION
IIb. Delivering the Golden Egg”
IPOs, M&A and Partnering in the Life Sciences Industry
|
Investors put money into emerging life science companies expecting to profitably take money out later. This “exit” ordinarily takes the form of either going public or being acquired by a larger company. What is the current status of IPOs and M&A in the industry? And how does partnering affect the eventual exit for a company? Our panel of industry experts will provide
up-to-date insights. |
Close |
|
Medical Device Association |
|
|
John G. Edwards; Moderator, Chief Executive Officer, Apeliotus Technologies
|
|
|
Why Medical Devices are Hot |
|
|
Keith A. Barritt; Prinicpal, Fish & Richardson P.C. |
|
|
Ted Davis; Vice President, Business Development, Wright Medical Group |
|
|
Al Lauritano; Director, Business Development, BD Technologies
|
|
|
Georgia Makes its Mark in Medical Devices |
|
|
Mark J. Phelps, PhD.; Senior Vice President of Research and Development,
LIFESYNC Incorporated |
|
|
Robert Scott, PhD; Director, Polymer Research, CIBA Vision Corporation |
|
|
Brian Walsh; President, Dornier MedTech America
|
|
IIb. |
“Delivering the Golden Egg” - IPOs, M&A and Partnering in the Life Sciences Industry |
|
|
Howard D. Palefsky; Moderator, General Partner/Managing Member,
Montreux Equity Partners |
|
|
Steven P. Damon; Vice President, Business Development, Altea Therapeutics |
|
|
Randy Guggenheimer; Managing Director, Burrill & Company |
|
|
Bruce C. Robertson, PhD; Managing Director, H.I.G. Ventures |
|
|
John W. Sharkey, PhD; Vice President, Business Development, Sciele Pharma, Inc.
|
|
IIc. Bioenergy: A Fuel for Success |
|
|
Jill Stuckey; Moderator, Director, Georgia Energy Innovation Center |
|
|
Nathan McClure; Moderator, Director of Forest Energy and Development,
Georgia Forestry Commission |
|
|
Ron Barmore; Director of Project Development, Range Fuels, Inc. |
|
|
James Fang, PhD; Director of Engineering, Sriya Innovations, Inc. |
|
|
Joy Doran Peterson, PhD; Assistant Professor of Microbiology,
The University of Georgia
|
|
IId.
|
Why Georgia?: The Ascent and Maturation of Georgia's Talent Pool and Biotech Labor Market presented by The GaBio Emerging Leaders Network |
|
|
Blaine W. Lindsey; Moderator, Attorney at Law, Representative, GaBio Emerging
Leaders Network |
|
|
Mark Banks; Vice President of Human Resources, Sciele Pharma, Inc. |
|
|
Amanda DePalma; Director, Global Strategic Marketing, Kimberly-Clark Health Care |
|
|
Jeffrey M. Humphreys; Director, Selig Center, Terry College of Business,
The University of Georgia
|
4:20 PM |
Introduction of Governor Sonny Perdue
Michelle Williams; Alston and Bird LLP
Keynote Address
The Honorable Sonny Perdue, DVM; Governor, State of Georgia
|
|
Georgia Bio Honors Senator Bob Dole for His Contribution to University-based Innovation
Senator Bob Dole; Special Counsel, Alston and Bird LLP
|
|
28 Years of Impact: The Bayh-Dole Act Accelerated the Realization of Georgia’s Biotechnology Economy |
|
C. Michael Cassidy; Moderator, President and Chief Executive Officer, Georgia Research Alliance |
|
Michael F. Adams, PhD; President, The University of Georgia |
|
James W. Wagner, PhD; President, Emory University
|
| |
Concluding Remarks
Senator Bob Dole; Special Counsel, Alston and Bird LLP
|
5:50 PM |
Announcement of Poster Winners |
|
Anthony J. Shuker, PhD; Moderator |
|
David Wynes, PhD; Moderator, Vice President for Research Administration,
Emory University
|
| |
Presentation of Awards
Stephen Bell, PhD, MBA; Senior Vice President, Saint Joseph’s Translational Research Institute
|
6:05 PM |
Closing Remarks
Thomas H. Callaway, MD; President, Life Science Partner and Managing Director,
Georgia Venture Partners
|
6:15 PM |
Gala Party
Casino Night at the Georgia World Congress Center |
|
|